213 related articles for article (PubMed ID: 24827470)
1. Asiatic acid attenuates cardiac hypertrophy by blocking transforming growth factor-β1-mediated hypertrophic signaling in vitro and in vivo.
Si L; Xu J; Yi C; Xu X; Wang F; Gu W; Zhang Y; Wang X
Int J Mol Med; 2014 Aug; 34(2):499-506. PubMed ID: 24827470
[TBL] [Abstract][Full Text] [Related]
2. Asiatic acid inhibits cardiac hypertrophy by blocking interleukin-1β-activated nuclear factor-κB signaling in vitro and in vivo.
Xu X; Si L; Xu J; Yi C; Wang F; Gu W; Zhang Y; Wang X
J Thorac Dis; 2015 Oct; 7(10):1787-97. PubMed ID: 26623102
[TBL] [Abstract][Full Text] [Related]
3. The TIR/BB-loop mimetic AS-1 prevents cardiac hypertrophy by inhibiting IL-1R-mediated MyD88-dependent signaling.
Zhu Y; Li T; Song J; Liu C; Hu Y; Que L; Ha T; Kelley J; Chen Q; Li C; Li Y
Basic Res Cardiol; 2011 Sep; 106(5):787-99. PubMed ID: 21533832
[TBL] [Abstract][Full Text] [Related]
4. TGF-beta1 induces cardiac hypertrophic responses via PKC-dependent ATF-2 activation.
Lim JY; Park SJ; Hwang HY; Park EJ; Nam JH; Kim J; Park SI
J Mol Cell Cardiol; 2005 Oct; 39(4):627-36. PubMed ID: 16125722
[TBL] [Abstract][Full Text] [Related]
5. B-type natriuretic peptide attenuates cardiac hypertrophy via the transforming growth factor-ß1/smad7 pathway in vivo and in vitro.
He JG; Chen YL; Chen BL; Huang YY; Yao FJ; Chen SL; Dong YG
Clin Exp Pharmacol Physiol; 2010 Mar; 37(3):283-9. PubMed ID: 19719752
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of farnesyl pyrophosphate synthase attenuates angiotensin II-induced cardiac hypertrophy and fibrosis in vivo.
Yang J; Zhu HH; Chen GP; Ye Y; Zhao CZ; Mou Y; Hu SJ
Int J Biochem Cell Biol; 2013 Mar; 45(3):657-66. PubMed ID: 23277274
[TBL] [Abstract][Full Text] [Related]
7. Loss of LRRC25 accelerates pathological cardiac hypertrophy through promoting fibrosis and inflammation regulated by TGF-β1.
Zhang X; Zhang MC; Wang CT
Biochem Biophys Res Commun; 2018 Nov; 506(1):137-144. PubMed ID: 30340835
[TBL] [Abstract][Full Text] [Related]
8. Globular adiponectin inhibits angiotensin II-induced nuclear factor kappaB activation through AMP-activated protein kinase in cardiac hypertrophy.
Wang C; Li L; Zhang ZG; Fan D; Zhu Y; Wu LL
J Cell Physiol; 2010 Jan; 222(1):149-55. PubMed ID: 19780028
[TBL] [Abstract][Full Text] [Related]
9. Eicosapentaenoic acid prevents endothelin-1-induced cardiomyocyte hypertrophy in vitro through the suppression of TGF-beta 1 and phosphorylated JNK.
Shimojo N; Jesmin S; Zaedi S; Maeda S; Soma M; Aonuma K; Yamaguchi I; Miyauchi T
Am J Physiol Heart Circ Physiol; 2006 Aug; 291(2):H835-45. PubMed ID: 16501010
[TBL] [Abstract][Full Text] [Related]
10. Asiatic Acid Attenuates the Progression of Left Ventricular Hypertrophy and Heart Failure Induced by Pressure Overload by Inhibiting Myocardial Remodeling in Mice.
Si L; Xu J; Yi C; Xu X; Ma C; Yang J; Wang F; Zhang Y; Wang X
J Cardiovasc Pharmacol; 2015 Dec; 66(6):558-68. PubMed ID: 26647013
[TBL] [Abstract][Full Text] [Related]
11. Celastrol-Induced Suppression of the MiR-21/ERK Signalling Pathway Attenuates Cardiac Fibrosis and Dysfunction.
Cheng M; Wu G; Song Y; Wang L; Tu L; Zhang L; Zhang C
Cell Physiol Biochem; 2016; 38(5):1928-38. PubMed ID: 27160852
[TBL] [Abstract][Full Text] [Related]
12. Growth differentiation factor 15 acts anti-apoptotic and pro-hypertrophic in adult cardiomyocytes.
Heger J; Schiegnitz E; von Waldthausen D; Anwar MM; Piper HM; Euler G
J Cell Physiol; 2010 Jul; 224(1):120-6. PubMed ID: 20232299
[TBL] [Abstract][Full Text] [Related]
13. Genistein attenuates pathological cardiac hypertrophy in vivo and in vitro.
Meng Y; Zhang Y; Ma Z; Zhou H; Ni J; Liao H; Tang Q
Herz; 2019 May; 44(3):247-256. PubMed ID: 29101624
[TBL] [Abstract][Full Text] [Related]
14. TGF-beta1 improves cardiac performance via up-regulation of laminin receptor 37/67 in adult ventricular cardiomyocytes.
Wenzel S; Henning K; Habbig A; Forst S; Schreckenberg R; Heger J; Maxeiner H; Schlüter KD
Basic Res Cardiol; 2010 Sep; 105(5):621-9. PubMed ID: 20556404
[TBL] [Abstract][Full Text] [Related]
15. DY-9760e inhibits endothelin-1-induced cardiomyocyte hypertrophy through inhibition of CaMKII and ERK activities.
Lu YM; Shioda N; Han F; Kamata A; Shirasaki Y; Qin ZH; Fukunaga K
Cardiovasc Ther; 2009; 27(1):17-27. PubMed ID: 19207476
[TBL] [Abstract][Full Text] [Related]
16. Mechanical stretch via transforming growth factor-β1 activates microRNA-208a to regulate hypertrophy in cultured rat cardiac myocytes.
Wang BW; Wu GJ; Cheng WP; Shyu KG
J Formos Med Assoc; 2013 Oct; 112(10):635-43. PubMed ID: 24120154
[TBL] [Abstract][Full Text] [Related]
17. Asiatic acid inhibits cardiac fibrosis throughNrf2/HO-1 and TGF-β1/Smads signaling pathways in spontaneous hypertension rats.
Meng Z; Li HY; Si CY; Liu YZ; Teng S
Int Immunopharmacol; 2019 Sep; 74():105712. PubMed ID: 31254954
[TBL] [Abstract][Full Text] [Related]
18. Vasopressin promotes cardiomyocyte hypertrophy via the vasopressin V1A receptor in neonatal mice.
Hiroyama M; Wang S; Aoyagi T; Oikawa R; Sanbe A; Takeo S; Tanoue A
Eur J Pharmacol; 2007 Mar; 559(2-3):89-97. PubMed ID: 17275806
[TBL] [Abstract][Full Text] [Related]
19. Puerarin attenuates pressure overload-induced cardiac hypertrophy.
Yuan Y; Zong J; Zhou H; Bian ZY; Deng W; Dai J; Gan HW; Yang Z; Li H; Tang QZ
J Cardiol; 2014 Jan; 63(1):73-81. PubMed ID: 23906530
[TBL] [Abstract][Full Text] [Related]
20. COX-2 is involved in ET-1-induced hypertrophy of neonatal rat cardiomyocytes: role of NFATc3.
Li H; Gao S; Ye J; Feng X; Cai Y; Liu Z; Lu J; Li Q; Huang X; Chen S; Liu P
Mol Cell Endocrinol; 2014 Feb; 382(2):998-1006. PubMed ID: 24291639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
